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The authors claim that the silicon supplement ‘Monomethylsilanetriol’ (MMST) is safe and is converted to orthosilicic
acid (OSA) after ingestion. Critical analysis of the study results indicates that the presented data are insufficient to
conclude that the use of MMST in food or food supplements is safe. Long term safety studies in humans and
toxicological testing in vitro and in animals are an absolute requisite for such a conclusion but these are lacking in
the present study and in the literature. Furthermore, none of the presented data show that MMST is actually
converted to OSA, as OSA was not analyzed in neither serum or urine of supplemented subjects.
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Letter to the Editor
Dear Editor,
In the recent article by Jugdaohsingh et al. (Nutrition &
Metabolism 2013, 10:37) the authors claim that the silicon
supplement ‘Monomethylsilanetriol’ (MMST) is safe and is
converted to orthosilicic acid (OSA) after ingestion.
MMST has been used in liquid food supplements in
Europe but no formal safety data are available. This is one
of the reasons why The European Food Safety Authorithy
(EFSA) [1] has given a negative opinion w.r.t. the use of
MMST for nutritional purposes to food supplements and
why MMST is not included in Annex II of EC Regulation n
° 1170/2009 [2] which lists the vitamins and minerals and
their forms that can be added to food and food supple-
ments. Consequently, starting from January 2010, the use
of MMST in food supplements is prohibited in Europe.
As background information on the biological activity of
MMST, the authors refer to animal and clinical studies.
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reproduction in any medium, provided the orblind, randomized studies and were done in small numbers
of patients. Therefore, these preliminary results should be
treated with the necessary precaution and are certainly no
basis to hypothesize that MMST is converted to OSA.
The authors performed a 4 weeks’ supplementation cross-
over study with MMST in 22 healthy, pre-menopausal
women. Since no adverse effects were reported and no bio-
chemical changes were observed after MMST supplementa-
tion, the authors conclude that the use of MMST is safe.
But are there enough data to make such a general
conclusion?
First, a supplementation period of 4 weeks is very short
and therefore not sufficient, i.e. long term studies are abso-
lutely necessary taken into account that food supplements
are typically used by consumers for several months and
even years.
Second, only 22 subjects were recruited of which only 14
and 18 participants had complete data sets (respectively 14
for serum and 18 for urine). It is incomprehensible how the
authors make a general conclusion w.r.t. safety based on
such a limited number of data. Furthermore, no reference is
made to the standard battery of toxicity studies i.e. acute
toxicity, subchronic and chronic toxicity, genotoxicity,ral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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studies been done previously? No such studies can be found
on PubMed. On the contrary, in a study co-authored by one
of the present authors [3], it was shown that dimethylsilane-
diol was highly phytotoxic and to a lesser degree also mono-
methylsilanetriol. Based on this documented phytoxicity it
was concluded that these organic silanols cannot be consid-
ered as substitutes for silicic acid in plants. This clearly illus-
trates that (ortho)silicic acid is metabolized differently than
organic silanols in eukaryotes. In fact, a recent study indi-
cates that silanetriol can be seen as an analogue of silicic
acid with a specific and potential therapeutic activity as it
was found to inhibit the hydrolytic enzyme acetylcholines-
tearase [4]. In another recent study it was shown that the
growth rate of the silicon dependent diatom C. fusiformis,
was only 25–30% of the growth rate observed for silicic
acid when hydroxymethylsilanetriol was used in the cul-
ture medium [5]. Analogues are frequently used in the
development of new drugs but caution is certainly needed
for the application in food. Profound toxicity and ADME
studies are needed to evaluate the safety of these organic
silanols, including MMST. MMST and similar (ortho)sili-
cic acid analogues could also be used to elucidate the
role of Si, still a crypto element for scientists, in connect-
ive tissue and human physiology.
In addition, I have some serious concerns regarding
the study lay out.
Only young (aged 22–38 years) healthy pre-menopausal
females participated the study. Men, post-menopausal
women and older women were excluded. The study popu-
lation is therefore not a representative sample of the nor-
mal population, which is considered as a prerequisite for
performing adequate safety studies.
A minimum fasting time between the last ingestion
and blood/urine sampling of 10 hours was used. How-
ever, what about the participants’ diet during these
4 weeks supplementation period? Were there any re-
strictions or not? Was the consumption of high Si con-
taining sources (e.g. beans, cereals, beer) allowed and
monitored? The fact that MMST was detected in some
baseline urine samples (see section Discussion, pg 7)
suggest that the 10-hour fasting time in this study was
not sufficient and could result in a cumulative effect on
silicon serum and urine concentrations. I also agree with
Dr. Exley who posted a relevant comment on the Jour-
nal’s website that the authors have reported the urinary
silicon excretion as mg/l for point samples which means
that these results do not take into account differences in
glomerular filtration rate. This implies that the reported
results cannot be used to make comparisons between
groups within the same study i.e. MMST supplementa-
tion versus placebo.
Nothing is mentioned about a wash-out period be-
tween the 2 treatment periods (placebo and MMST),although it is a standard procedure in cross-over studies
to eliminate bias.
The analysis of MMST in serum was restricted to only
9 serum samples and 10 urine samples. After ingestion
of MMST the organosilicon concentration in urine and
serum was calculated to account for 10% and ca. 50% of
the increase in total Si in the fasting urine and serum
samples, respectively. This observation is used by the
authors to conclude that MMST has been converted to
OSA, without analyzing OSA itself in body fluids. I do not
agree with such a conclusion for the following reasons.
The authors forget to mention that after ingestion MMST
can also undergo tissue loading in connective tissue and
organs, which would explain why 10% is retrieved in urine
and 50% in serum. Without MMST analysis in tissues and
without the detection of OSA in bodyfluids one cannot
conclude that MMST has been converted to OSA. The
changes in silicon concentration in urine and serum, can
in part be caused by differences in dietary intake and in the
case of urine by differences in glomerular filtration rate,
consequently calculations such as “10 or 50% of the in-
crease in total Si” are invalid.. Interestingly, in a previous
article of the authors on the bioavailability of MMST [6],
they noted that the rapid absorption of MMST is “presum-
ably related to the organic moiety, which may allow rapid
penetration of the intestinal mucosa by the molecule”, i.e.
they conclude that MMST is not converted to OSA in the
GI tract. The fact that a large quantity (“50%”) of MMST is
detected in serum is also contradictory to the authors’ con-
clusion that MMST is converted to OSA.
In the Discussion section, the authors claim that stable
isotopic labeling with 29Si cannot be performed due to its
relative high natural abundance and the relative insensitivity
of 29Si by NMR. This is incorrect. 29Si NMR detection limits
are sufficiently sensitive [7] as pointed out by one of the au-
thors in a previous publication. In fact, exactly such a speci-
ation study with 29Si NMR was previously done for another
Si supplement, showing that this compound is converted to
OSA, after ingestion [8]. This stable isotope methodology
was also used by one of the authors to detect orthosilicic
acid in biological samples with 29Si NMR [9]. Since no such
speciation study was performed, concrete evidence for the
conversion of MMST to OSA is totally lacking in the
present study. Therefore the authors’ conclusion that follow-
ing ingestion, MMST is converted to OSA is not proven by
objective data.
Based on this 4 week study one cannot conclude that
MMST supplementation is safe for the general public.
Long-term safety studies in humans and toxicological
testing in vitro and in animals are an absolute requisite
but such studies are lacking for MMST. Furthermore,
none of the presented data show that MMST is actually
converted to OSA, as OSA was has not been analyzed in
neither serum or urine.
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